A type IV hypersensitivity reaction, Th2-mediated and driven by interleukin-4 (IL-4), IL-5 and IL-13, promoting IgE production by B cells and activating eosinophils and mast cells, has been suggested. Here, IL13 is linked to type IV hypersensitivity disease.